A

ABVC BioPharma
D

ABVC

0.52250
USD
-0.02
(-3.24%)
Market Closed
Volume
54
EPS
-0
Div Yield
-
P/E
-1
Market Cap
6,397,731
News

Title: ABVC BioPharma

Sector: Healthcare
Industry: Biotechnology
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.